

NRT Smoking Cessation Aids
Total report count: 49
- All
- Country Report
Why buy our reports
- Understand an industry, category and markets quickly
- Robust data from a trusted source
- Comprehensive, data-driven insights
- Leverage our expert knowledge for an unbiased view
Get in touch
Want to find out more about our reports?
Contact us and a member of the team will respond promptly.
NRT smoking cessation aids in Switzerland declined in retail volume terms and witnessed limited value growth in 2025. Consumers have a large selection of alternatives to smoking, which partly hinders the use of cessation aids. A growing number of younger consumers prefer alternatives such as vapes and Snus. Nonetheless, the decline in smoking prevalence provides a prime target audience.
Value sales of NRT smoking cessation aids increased in Belgium in 2025, signalling a modest but meaningful recovery for a category that had previously been in decline. For several years, the rising popularity of vaping products had diverted consumers away from traditional NRT formats, such as gums, patches, and lozenges, as smokers increasingly turned to e-cigarettes as an alternative cessation method.
NRT smoking cessation aids in the United Arab Emirates is expected to continue to grow healthily in retail volume and current value terms over 2025. Beyond official efforts to curb smoking (eg high tobacco taxes), the growing focus on holistic wellness is driving interest in nicotine replacement therapies (NRTs). As more consumers adopt healthier lifestyles and aim to improve both their mental and physical wellbeing, the demand for effective smoking cessation aids is on the rise. Increasing awar
Value sales of NRT smoking cessation aids in Bulgaria increased in 2025. Bulgaria remains one of the countries with the highest smoking rates in Europe and globally, with nearly four in ten adults using tobacco products and a high prevalence of smoking among adolescents aged 13-15. This widespread tobacco consumption continues to create a strong potential market for nicotine replacement therapies (NRT). Rising awareness of the health risks associated with smoking and growing familiarity with ces
In 2025, retail value sales of NRT smoking cessation aids increased in Norway, though growth slowed compared to the previous year. The primary driver of growth remains strong public health messaging and an enduring desire among smokers to quit for health reasons. However, the market is increasingly constrained by a shrinking pool of daily smokers.
Retail value sales of nicotine replacement therapy (NRT) smoking cessation aids are expected to fall in current terms in Japan in 2025. The category is continuing its slow decline, driven primarily by the shrinking base of smokers and the growing shift towards heated tobacco products. However, several external factors temporarily stimulated demand during the year.
Value sales of NRT smoking cessation aids in the Czech Republic decreased in 2025. The product area contracted as consumer behaviour shifted towards alternatives such as vaping and nicotine pouches, which are increasingly perceived as modern and effective solutions. The category’s volatility is amplified by the limited number of active brands and its dependence on the pharmacy channel, where NRTs receive less promotional support compared to other OTC categories. While smoking prevalence remains
Sales of NRT smoking cessation aids have declined in current value terms in 2025. The decline in sales of NRT smoking cessation aids in the US reflects the continued decline in the smoking population overall. The value decline is also attributable to the increasing consumer preference for private label products over branded products during a year marked by uncertainty over regulatory tariffs and the threat of recession.
Retail value sales of nicotine replacement therapy (NRT) smoking cessation aids are set to rise in current term sin the UK in 2025. This growth is being driven by heightened public health awareness, increased government support for cessation programmes, and a growing preference for healthier lifestyles. The NHS’s continued investment in smoking cessation services, alongside the UK Government's “Smokefree 2030” ambition, has played a pivotal role in encouraging smokers to quit. Additionally, the
Retail value sales of NRT smoking cessation aids are set to decline in current terms in South Korea in 2025, largely due to the rapid growth of the electronic and liquid cigarette segment. Many smokers are now turning to e-cigarettes as a way to gradually reduce nicotine intake, viewing them as a more flexible and socially acceptable alternative to traditional cessation aids. This shift has reduced demand for conventional nicotine replacement therapies, such as patches, gums and lozenges.
In Colombia in 2025, value sales of NRT smoking cessation aids are low and flat, while volume sales declining deeply. Although Colombian consumers’ interest in quitting smoking remains high, NRT smoking cessation aids are not the first choice when beginning to tackle smoking addiction. A gradual reduction in the number of daily cigarettes is the top choice, as revealed by the Euromonitor report, Voice of the Consumer: Health and Nutrition; for 57% of smokers this is the first approach, followed
NRT smoking cessation aids in Germany is projected to see a further decline in retail volume sales in 2025, although still significant inflation is set to support a moderate increase in retail current value sales. Although smoking rates in Germany remain relatively high, they are falling year-on-year, as is the potential consumer base for NRT smoking cessation aids. Additionally, many traditional smokers are opting for perceived less harmful alternatives, such as e-vapour products and heated tob
What if your smartest decision is just a question away?
Passport is our award-winning knowledge hub for forward thinkers. Demolish doubt and turn your ideas into data-backed strategies.
Value sales of NRT smoking cessation aids are increasing in Mexico in 2025, with growth surpassing levels seen in recent years driven by an increasing number of users entering the category for health reasons. According to the 2023 Global Adult Tobacco Survey (GATS), the percentage of adult smokers in Mexico who received professional advice to quit smoking rose significantly from 17.3% in 2009 to 42.3% in 2023. This increase reflects greater awareness of the health risks associated with smoking a
NRT smoking cessation aids witnessed slightly slower value growth in 2025. Growth is driven by consumer attempts to reduce or quit smoking, which often takes multiple attempts and can involve consumption of multiple products such as patches and gum as consumers look for the most effective solution. NRT inhalators was the most dynamic category in 2025, although it is growing from a low base. Euromonitor’s Voice of the Consumer: Health and Nutrition survey shows the share of Canadian smokers tryin
Current value sales of NRT smoking cessation aids increased in Argentina in 2025 as tobacco sales declined. The decline in smoking prevalence was primarily attributed to heightened health awareness among local consumers.
Value sales of NRT smoking cessation aids increased in 2025, reflecting the ongoing efforts of Austrian smokers to reduce or quit their tobacco use. Although smoking prevalence continues to decline only gradually, about one in five adults still smokes at least occasionally, providing a stable consumer base for cessation products. Many individuals find it difficult to quit abruptly, especially during periods of heightened stress and anxiety, and NRT aids are perceived as more practical and afford
Sales of NRT smoking cessation aids have seen moderate growth in current value terms in 2025, reflecting a sustained decline in smoking rates nationwide. The latest data from the Australian Institute of Health and Welfare’s National Drug Strategy Household Survey shows that daily smoking among Australians aged 14 and over had dropped to just 8% in 2023, a dramatic fall from 24% in 1991. Meanwhile, 65% of respondents in 2023 reported never having smoked, highlighting the long-term impact of publi
NRT smoking cessation aids in Brazil is expected to see dynamic retail current value growth in 2024. However, most of this growth is being driven by price rises, as volume sales are expected to see only negligible growth. Nicotine patches is one of the most established formats for nicotine replacement therapy. However, these products are expensive, which limits the growth potential. Complete treatment with NRT patches accounts for more than 10% of the average Brazilian’s monthly income. Studies
The health and wellness movement is playing a pivotal role in shaping consumer behaviour in India. As an increasing number of people prioritise their fitness, mental health, and disease prevention, smoking cessation has emerged as a natural step towards achieving these goals. Younger, urban demographics are particularly influenced by this trend, viewing quitting as an essential aspect of a healthier lifestyle. This is set to drive double-digit retail current value growth for NRT smoking cessatio
In recent years, the Singaporean government has implemented a range of comprehensive initiatives to reduce its the prevalence of smoking among consumers, which in turn, has had a positive impact on demand for NRT smoking cessation aids. These efforts have included stricter regulations, public health campaigns, and targeted programmes aimed at raising awareness about the dangers of smoking and the benefits of quitting. As a result, there has been a noticeable decline in the average number of ciga
NRT smoking cessation aids in Romania are grappling with significant challenges, primarily due to rising inflation and shifting consumer preferences. Although volume sales in this category are projected to decline in 2024, current market value is anticipated to increase, mainly due to heightened pricing strategies. Moreover, despite having one of the highest smoking rates in Europe, consumer awareness of these products remains low. Although the Nicorette brand is advertised, its campaigns tend t
NRT smoking cessation aids is expected to register volume decline in 2024. While smoking rates continue to be high in Poland, they are falling year-on-year and therefore the potential consumer base for NRT smoking cessation aids is also declining year-on-year. In addition, many traditional smokers are instead opting for what are perceived as less harmful alternatives such as e-vapour products and heated tobacco. This is also dampening volume growth of NRT smoking cessation aids.
NRT smoking cessation aids in South Africa remains a small but growing category in consumer health, with NRT gum the only format registering sales. Other products such as NRT patches are available but cannot be purchased online as they can only be dispensed on a monthly basis as a scheduled medication.
NRT smoking cessations aids came under further pressure in 2024 as smoking prevalence in Sweden continued to fall in line with rising health-consciousness. With only around one in 16 Swedes claiming to smoke, there is a limited potential consumer base for NRT smoking cessation aids. With fewer smokers in Sweden, brands have a smaller base to target. As a result, retail volume sales continue to decline. Nevertheless, there is a generally negative attitude towards smoking a desire to quit.

What can we help you achieve?
Find the answers to your questions about Euromonitor International and our services.
Get started